Legal & General Group PLC Agios Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 73,101 shares of AGIO stock, worth $3.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,101
Previous 73,101 -0.0%
Holding current value
$3.93 Million
Previous $3.25 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$41.19 - $49.72 $509,767 - $615,334
12,376 Added 20.38%
73,101 $3.25 Million
Q2 2024

Aug 14, 2024
BUY
$27.55 - $48.83 $144,334 - $255,820
5,239 Added 9.44%
60,725 $2.62 Million
Q1 2024

May 14, 2024
BUY
$21.32 - $34.81 $10,766 - $17,579
505 Added 0.92%
55,486 $1.62 Million
Q4 2023

Feb 15, 2024
BUY
$19.97 - $24.53 $19,271 - $23,671
965 Added 1.79%
54,981 $1.22 Million
Q3 2023

Nov 14, 2023
BUY
$24.36 - $28.18 $50,498 - $58,417
2,073 Added 3.99%
54,016 $1.34 Million
Q2 2023

Aug 14, 2023
BUY
$21.38 - $29.19 $70,190 - $95,830
3,283 Added 6.75%
51,943 $1.47 Million
Q1 2023

May 15, 2023
BUY
$21.74 - $30.93 $27,457 - $39,064
1,263 Added 2.66%
48,660 $1.12 Million
Q4 2022

Feb 14, 2023
BUY
$24.81 - $31.52 $29,871 - $37,950
1,204 Added 2.61%
47,397 $1.33 Million
Q3 2022

Nov 14, 2022
SELL
$19.51 - $34.14 $17,578 - $30,760
-901 Reduced 1.91%
46,193 $1.31 Million
Q2 2022

Aug 22, 2022
SELL
$17.06 - $31.42 $18,851 - $34,719
-1,105 Reduced 2.29%
47,094 $1.04 Million
Q1 2022

May 16, 2022
SELL
$26.68 - $34.81 $6,936 - $9,050
-260 Reduced 0.54%
48,199 $1.4 Million
Q4 2021

Feb 14, 2022
SELL
$29.58 - $49.78 $26,444 - $44,503
-894 Reduced 1.81%
48,459 $1.59 Million
Q3 2021

Nov 15, 2021
BUY
$41.92 - $58.18 $464,012 - $643,994
11,069 Added 28.91%
49,353 $2.28 Million
Q2 2021

Aug 12, 2021
BUY
$52.06 - $61.27 $61,639 - $72,543
1,184 Added 3.19%
38,284 $2.11 Million
Q1 2021

May 17, 2021
BUY
$44.23 - $57.5 $234,772 - $305,210
5,308 Added 16.7%
37,100 $1.92 Million
Q4 2020

Feb 12, 2021
SELL
$33.21 - $46.54 $509,175 - $713,551
-15,332 Reduced 32.54%
31,792 $1.38 Million
Q3 2020

Nov 13, 2020
SELL
$33.87 - $55.93 $6,909 - $11,409
-204 Reduced 0.43%
47,124 $1.65 Million
Q2 2020

Aug 14, 2020
BUY
$34.45 - $53.48 $170,355 - $264,458
4,945 Added 11.67%
47,328 $2.53 Million
Q1 2020

May 14, 2020
BUY
$31.52 - $53.81 $150,098 - $256,243
4,762 Added 12.66%
42,383 $1.5 Million
Q4 2019

Feb 13, 2020
BUY
$30.08 - $50.59 $38,652 - $65,008
1,285 Added 3.54%
37,621 $1.8 Million
Q3 2019

Nov 13, 2019
BUY
$32.4 - $49.58 $171,298 - $262,129
5,287 Added 17.03%
36,336 $1.18 Million
Q2 2019

Aug 14, 2019
BUY
$46.17 - $68.1 $24,008 - $35,412
520 Added 1.7%
31,049 $1.55 Million
Q1 2019

May 15, 2019
BUY
$45.92 - $67.67 $27,781 - $40,940
605 Added 2.02%
30,529 $2.06 Million
Q4 2018

Feb 15, 2019
BUY
$42.73 - $76.53 $147,845 - $264,793
3,460 Added 13.07%
29,924 $1.38 Million
Q3 2018

Nov 20, 2018
BUY
$71.67 - $91.95 $194,870 - $250,012
2,719 Added 11.45%
26,464 $2.04 Million
Q2 2018

Aug 10, 2018
SELL
$73.22 - $99.55 $53,670 - $72,970
-733 Reduced 2.99%
23,745 $2 Million
Q1 2018

May 17, 2018
SELL
$59.83 - $86.53 $7 Million - $10.1 Million
-116,931 Reduced 82.69%
24,478 $2 Million
Q4 2017

Feb 13, 2018
BUY
$52.12 - $72.33 $7.37 Million - $10.2 Million
141,409
141,409 $8.09 Million

Others Institutions Holding AGIO

# of Institutions
234
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.95B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email